The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move could jeopardize the availability of cheaper, generic forms of those drugs ...

Treatment availability and patient outcomes are critical issues for the pharmaceutical industry, particularly in eye care.

Some patients are facing delays or breaks in their treatment due to shortages of certain medicines, with hundreds of drugs ...

Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

Online yoga classes relieved chronic low back pain and slashed the need for pain-relief medications, a new study shows.

President-elect Donald Trump’s nominee would oversee agencies that regulate food, vaccines and medicine and were instrumental ...

Lindsay Bealor Greenleaf, JD, MBA, of ADVI Health, weighs in on what to expect in key health care policy areas in the wake of ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

Good afternoon, and welcome to Fractyl Health's Third Quarter Financial Results and Business Updates Call. As a reminder, this conference call is being recorded. [Operator Instructions]. I will now ...

Three patients in the UK receive ‘groundbreaking’ treatment for lupus - There is currently no cure for lupus and people often ...